Active Pharmaceutical Ingredient (API) Market Size & Share, by API Type (Branded, Generic); Synthesis Type (Biotech, Synthetic); Application (Cardiology, Oncology, Pulmonology, Neurology, Ophthalmology) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4214
  • Published Date: Feb 20, 2023
  • Report Format: PDF, PPT

Companies Dominating the Active Pharmaceutical Ingredient Landscape

    • Teva Pharmaceutical Industries Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Abbott Laboratories
    • AbbVie Inc.
    • Mylan N.V.
    • GSK plc
    • Eli Lilli and Company
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Merck & Co. Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Pfizer Inc. acquires U.S. FDA approval along with Myovant for MYFEMBREE, a once-daily treatment for premenopausal women with endometriosis to reduce non-menstrual and menstrual pain. Additionally, both companies are jointly commercializing MYFEMBREE with immediate product availability.

  • Abbott Laboratories to collaborate with WW International, Inc. to integrate WeightWatchers, a weight management program, to provide requisite assistance to people diagnosed with diabetes and improvise their health issues.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4214
  • Published Date: Feb 20, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The higher prevalence of chronic diseases across the globe and spiking cases of medication errors are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

Higher price associated with the manufacturing process and possibilities of side effects is estimated to challenge the market growth.

The market in North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Pfizer Inc., Abbott Laboratories, AbbVie Inc., Mylan N.V., GSK plc, Eli Lilli and Company, Sun Pharmaceutical Industries Ltd., Novartis AG, and Merck & Co. Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by API type, synthesis type, application, by region.

The cardiology segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying